Mark Edward Byrne (Mark Byrne, Mark E Byrne)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Molecularly Imprinted

Top Venues

Journal of materials chemistry. B

Journal of biomedical materials research. Part A

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Brendan Rucci, Brian Boyle, Mark Edward Byrne
Hollow Polyethyleneimine Nanoparticles with Drug Loaded DNA for Chemotherapeutic Applications. ChemPlusChem 89 (8) (2024)
Brendan Rucci, Brian Boyle, Mark Edward Byrne
Hollow Polyethyleneimine Nanoparticles with Drug Loaded DNA for Chemotherapeutic Applications. ChemPlusChem (2024)
Camila Vardar, Mindy George-Weinstein, Robert Getts, Mark Edward Byrne
Evaluation of Dose-Response Relationship in Novel Extended Release of Targeted Nucleic Acid Nanocarriers to Treat Secondary Cataracts. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (2024)
Robert J Mosley, Brendan Rucci, Mark Edward Byrne
Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery. Journal of materials chemistry. B (2023)
Robert J Mosley, Brendan Rucci, Mark Edward Byrne
Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery. Journal of materials chemistry. B 11 (10) (2023)
Robert J Mosley, Brendan Rucci, Mark Edward Byrne
Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery. Journal of materials chemistry. B 11 (10) (2023)
Robert J Mosley, Brendan Rucci, Mark Edward Byrne
Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery. Journal of materials chemistry. B 11 (10) (2023)
Liana Wuchte, Stephen DiPasquale, Ashlyn Masterson, Abigail Vance, Jonathan Goff, Barry Arkles, Santy Sulaiman, Mark Edward Byrne
Characterization and analysis of extended-wear silicone hydrogel contact lenses utilizing novel silicone macromers. Journal of biomedical materials research. Part A 110 (8) (2022)
Saoirse Casey-Power, Richie Ryan, Gautam Behl, Peter McLoughlin, Mark Edward Byrne, Laurence Fitzhenry
Hyaluronic Acid: Its Versatile Use in Ocular Drug Delivery with a Specific Focus on Hyaluronic Acid-Based Polyelectrolyte Complexes. Pharmaceutics 14 (7) (2022)
Laura L Osorno, Robert J Mosley, Patricia L Poley, Jessica Bowers, Grzegorz Gorski, Jacquelyn Gerhart, Robert Getts, Mindy George-Weinstein, Mark Edward Byrne
Sustained Release of Antibody-Conjugated DNA Nanocarriers from a Novel Injectable Hydrogel for Targeted Cell Depletion to Treat Cataract Posterior Capsule Opacification. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 38 (6) (2022)
Ayah Mohammad Burhan, Butsabarat Klahan, Wayne Cummins, Vanessa Andrés-Guerrero, Mark Edward Byrne, Niall J O'Reilly, Anuj Chauhan, Laurence Fitzhenry, Helen Hughes
Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan. Pharmaceutics 13 (10) (2021)
Laura L Osorno, Alyssa N Brandley, Daniel E Maldonado, Alex Yiantsos, Robert J Mosley, Mark Edward Byrne
Review of Contemporary Self-Assembled Systems for the Controlled Delivery of Therapeutics in Medicine. Nanomaterials (Basel, Switzerland) 11 (2) (2021)
Stephen A DiPasquale, Liana D Wuchte, Robert J Mosley, Renee M Demarest, Meredith L Voyles, Mark Edward Byrne
One Week Sustained In Vivo Therapeutic Release and Safety of Novel Extended-Wear Silicone Hydrogel Contact Lenses. Advanced healthcare materials (2021)
Ricky Whitener, Robert J Mosley, Jacek Wower, Mark Edward Byrne
Nucleic acid biohybrid nanocarriers with high-therapeutic payload and controllable extended release of daunomycin for cancer therapy. Journal of biomedical materials research. Part A 109 (7) (2020)